Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.91% |
| 2 | Technology | 7.43% |
| 3 | Financials | 6.52% |
| 4 | Consumer Discretionary | 5.69% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
PUT
Illumina
ILMN
$33.7B
| $7.02M | 0.02% |
26,420
+7,813
| +42% | +$2.18M |
|
1077
Allison Transmission
ALSN
$10.8B
| $7.02M | 0.02% |
215,193
+205,749
| +2,179% | +$8.58M |
|
|
ITCI
1078
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $7.01M | 0.02% |
456,133
+196,279
| +76% | +$4.26M |
|
1079
HSBC
HSBC
$357B
| $7M | 0.02% |
+250,067
| New | +$8.68M |
|
1080
WEX
WEX
$6.93B
| $6.99M | 0.02% |
66,834
+20,974
| +46% | +$3.92M |
|
|
CERN
1081
PUT
DELISTED
Cerner Corp
CERN
| $6.95M | 0.02% |
110,300
+13,100
| +13% | +$932K |
|
|
VBTX
1082
DELISTED
Veritex Holdings
VBTX
| $6.93M | 0.02% |
496,218
-350,772
| -41% | -$8.44M |
|
|
ACAMU
1083
DELISTED
Acamar Partners Acquisition Corp Units
ACAMU
| $6.93M | 0.02% |
700,000
| – | – |
|
1084
Evolent Health
EVH
$534M
| $6.93M | 0.02% |
1,275,767
-353,423
| -22% | -$3.16M |
|
1085
Regency Centers
REG
$14B
| $6.91M | 0.02% |
+179,745
| New | +$10.3M |
|
1086
Insmed
INSM
$27.1B
| $6.9M | 0.02% |
430,291
-394,419
| -48% | -$9.35M |
|
1087
Cactus
WHD
$5.46B
| $6.86M | 0.02% |
591,709
+222,752
| +60% | +$5.59M |
|
1088
BridgeBio Pharma
BBIO
$15.8B
| $6.85M | 0.02% |
+236,200
| New | +$7.32M |
|
1089
OneMain Financial
OMF
$7.23B
| $6.82M | 0.02% |
356,708
-347,577
| -49% | -$12.9M |
|
1090
Nordson
NDSN
$18.6B
| $6.82M | 0.02% |
50,454
-24,777
| -33% | -$3.81M |
|
1091
Prothena Corp
PRTA
$482M
| $6.81M | 0.02% |
636,810
+110,541
| +21% | +$1.34M |
|
1092
Matador Resources
MTDR
$7.12B
| $6.78M | 0.02% |
2,734,792
+2,084,229
| +320% | +$22.9M |
|
1093
Urban Edge Properties
UE
$2.73B
| $6.78M | 0.02% |
769,510
+276,976
| +56% | +$4.55M |
|
1094
Angi Inc
ANGI
$200M
| $6.75M | 0.02% |
128,611
+1,626
| +1% | +$121K |
|
1095
Silicon Motion
SIMO
$8.25B
| $6.75M | 0.02% |
184,037
-33,243
| -15% | -$1.44M |
|
|
IMGN
1096
DELISTED
Immunogen Inc
IMGN
| $6.75M | 0.02% |
1,978,258
-991,321
| -33% | -$4.33M |
|
1097
PagerDuty
PD
$956M
| $6.74M | 0.02% |
389,921
+348,139
| +833% | +$7.39M |
|
1098
Banner Corp
BANR
$2.41B
| $6.73M | 0.02% |
203,759
+38,529
| +23% | +$1.83M |
|
1099
Otter Tail
OTTR
$3.86B
| $6.73M | 0.02% |
151,317
-63,480
| -30% | -$3.16M |
|
1100
O-I Glass
OI
$1.11B
| $6.71M | 0.02% |
943,681
-766,349
| -45% | -$8.39M |
|
Similar funds
Israel Englander's Q1 2020 Portfolio in Review
As of Q1 2020, Israel Englander held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Danaher worth $133M.
- Israel Englander's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Israel Englander added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Israel Englander's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Israel Englander fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Israel Englander opened 789 new positions and closed 1,154 in Q1 2020.
- Israel Englander's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.